Browsing publications by Professor Ann Daly

Newcastle AuthorsTitleYear
Ching Ng
Dr Abul Hasnat
Professor Chris Day
Professor Ann Daly
N-acetyltransferase 2 (NAT2) genotype as a risk factor for development of drug-induced liver injury relating to antituberculosis drug treatment in a mixed-ethnicity patient group2014
Dr Yang-Lin LIU
Dr Gillian Patman
Julian Leathart
Professor Alastair Burt
Professor Chris Day
et al.
Carriage of the PNPLA3 rs738409 C>G Polymorphism Confers an Increased Risk of Non-Alcoholic Fatty Liver Disease Associated Hepatocellular Carcinoma2014
Julian Leathart
Professor Ann Daly
Professor Chris Day
Dr Quentin Anstee
Gene Polymorphisms of Cellular Senescence Marker P21 and Disease Progression in Non-Alcohol-Related Fatty Liver Disease2014
Professor Ann Daly
Is There a Need to Teach Pharmacogenetics?2014
Professor Ann Daly
Opportunities and limitations: the value of pharmacogenetics in clinical practice2014
Professor Ann Daly
Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon2014
Dr Yang-Lin LIU
Dr Helen Reeves
Professor Alastair Burt
Dr Dina Tiniakos
Dr Stuart McPherson
et al.
TM6SF2 rs58542926 Influences Hepatic Fibrosis Progression in Patients with Non-Alcoholic Fatty Liver Disease2014
Dr Quentin Anstee
Dr Rebecca Darlay
Julian Leathart
Yilei Liu
Professor Alastair Burt
et al.
A candidate-gene approach to validation of genetic modifier associations using a large cohort with histologically characterised non-alcoholic fatty liver disease2013
Dr Patrick Kesteven
Professor Ann Daly
Dr Peter Avery
Professor Farhad Kamali
A Randomized Trial Comparing Genotype-Guided Dosing of Warfarin to Standard Dosing: The EU Pharmacogenetics of Anticoagulant Therapy (EU-PACT) Warfarin Study2013
Dr Patrick Kesteven
Julian Leathart
Professor Ann Daly
Professor Farhad Kamali
A Randomized Trial of Genotype-Guided Dosing of Warfarin2013
1234567891011121314151617181920...